Renal vein thrombosis and membranous glomerulopathy in a patient homozygote for factor V Leiden mutation: A mere coincidence?

Thrombosis and Haemostasis

Volumn 95, Issue 4, 2006, Pages 740-743

  Elinav, Eran ^a   Rubinger, Dvora ^a   Hiller, Nurith ^a   Pizov, Galina ^a   Nadir, Eyal ^a   Shapira, Yami ^a   Heyman, Samuel N ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; ENALAPRIL; NAPROXEN; SIMVASTATIN; WARFARIN;

ACTIVATED PROTEIN C RESISTANCE; ADULT; ANTICOAGULANT THERAPY; ARTICLE; ATELECTASIS; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ERROR; DYSPNEA; FOLLOW UP; FOOT EDEMA; GENE MUTATION; HEMOPTYSIS; HOMOZYGOTE; HUMAN; HUMAN CELL; HYPERCHOLESTEROLEMIA; HYPOALBUMINEMIA; KIDNEY VEIN THROMBOSIS; LUNG EMBOLISM; MALE; MEMBRANOUS GLOMERULONEPHRITIS; PERIORBITAL EDEMA; PLEURA DISEASE; PLEURISY; PRIORITY JOURNAL; PROTEINURIA; THORAX PAIN; URINALYSIS;

ADULT; BLOOD CHEMICAL ANALYSIS; FACTOR V; GLOMERULONEPHRITIS, MEMBRANOUS; HOMOZYGOTE; HUMANS; KIDNEY GLOMERULUS; MALE; RENAL VEINS; VENOUS THROMBOSIS;

EID: 33645736047     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH05-08-0565     Document Type: Article

References (13)

1. Glassock RJ. Diagnosis and natural course of membranous nephropathy. Semin Nephrol 2003; 23: 324-32.
2. Dizon-Townson DS, Nelson LM, Jang H, et al. The incidence of the factor V Leiden mutation in an obstetric population and its relationship to deep vein thrombosis. Am J Obstet Gynecol 1997; 176: 883-6.
3. Juul K, Tybjaerg-Hansen A, Steffensen R, et al. Factor V Leiden: The Copenhagen City Heart Study and 2 meta-analyses. Blood 2002; 100: 3-10.
4. Heit JA, Sobell JL, Li H, et al. The incidence of venous thromboembolism among Factor V Leiden carriers: a community-based cohort study. J Thromb Haemost 2005; 3: 305-11.
5. Nickolas TL, Radhakrishnan J, Appel GB. Hyperlipidemia and thrombotic complications in patients with membranous nephropathy. Semin Nephrol 2003; 23: 406-11.
6. Rabelink TJ, Zwaginga JJ, Koomans HA, et al. Thrombosis and hemostasis in renal disease. Kidney Int 1994; 46: 287-96.
7. Llach F. Hypercoagulability, renal vein thrombosis, and other thrombotic complications of nephrotic syndrome. Kidney Int 1985; 28: 429-39.
8. Wagoner RD, Stanson AW, Holley KE, et al. Renal vein thrombosis in idiopathic membranous glomerulopathy and nephrotic syndrome: incidence and significance. Kidney Int 1983; 23: 368-74.
9. Pasquariello A, Camerini E. Unilateral renal vein thrombosis and pulmonary embolism complicating membranous nephropathy. Am J Nephrol 1992; 12: 134-6.
10. Alkjaersig N, Fletcher AP, Narayanan, et al. Course and resolution of the coagulopathy in nephrotic children. Kidney Int 1987; 31: 772-80.
11. Robert A, Olmer M, Sampol J, et al. Clinical correlation between hypercoagulability and thrombo-embolic phenomena. Kidney Int 1987; 31: 830-5.
12. Morrissey EC, McDonald BR, Rabetoy GM. Resolution of proteinuria secondary to bilateral renal vein thrombosis after treatment with systemic thrombolytic therapy. Am J Kidney Dis 1997; 29: 615-9.
13. Ozawa T, Boedecker EA, Schorr W et al. Immune-complex disease with unilateral renal vein thrombosis. Arch Pathol Lab Med 1976; 100: 279-82.